Detalles de la búsqueda
1.
CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer.
Pharmacol Res
; 194: 106850, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37453674
2.
Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling.
Pharmacol Res
; 171: 105574, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34419228
3.
Traditional Herbal Medicine: A Potential Therapeutic Approach for Adjuvant Treatment of Non-small Cell Lung Cancer in the Future.
Integr Cancer Ther
; 21: 15347354221144312, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36567455
4.
Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives.
Front Pharmacol
; 13: 875330, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35517800
5.
A method establishment and comparison of in vivo lung cancer model development platforms for evaluation of tumour metabolism and pharmaceutical efficacy.
Phytomedicine
; 96: 153831, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34794861
6.
Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease.
Chin Med
; 16(1): 108, 2021 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34686199
7.
Immune checkpoints and immunotherapy in non-small cell lung cancer: Novel study progression, challenges and solutions.
Oncol Lett
; 22(5): 787, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34594428
Resultados
1 -
7
de 7
1
Próxima >
>>